OPEN END TURBO LONG - IPSEN | Real-time Bid/Ask 12:32:08 03/06/2024 pm IST | ||
| 5.35 EUR / 5.38 EUR | -0.83% |
|
| 1 month | +15.60% | ||
| 3 months | +50.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 01/24/01 | 5.41 | +2.27% |
| 30/24/30 | 5.29 | +0.76% |
| 29/24/29 | 5.25 | -2.96% |
| 28/24/28 | 5.41 | +0.56% |
| 27/24/27 | 5.38 | -3.76% |
Delayed Quote Börse Stuttgart
Last update May 01, 2024 at 12:27 am IST
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MD5KFT |
| ISIN | DE000MD5KFT7 |
| Date issued | 27/06/2022 |
| Strike | 66.54 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.68 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.64 € |
|---|---|
| Lowest since issue | 2.43 € |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.6
EUR
Average target price
126.4
EUR
Spread / Average Target
+4.81%
- Stock Market
- Certificates
- Certificat
